11 – 20 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
Jóhannesson, Vilberg LU ; Gunnlaugsson, Adalsteinn LU ; Nilsson, Per LU
; Brynolfsson, Patrik
LU
; Kjellén, Elisabeth
LU
and Wieslander, Elinore
LU
(2024)
In Technical Innovations and Patient Support in Radiation Oncology
29.
- Contribution to journal › Article
-
Mark
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume : A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
Wieslander, Elinore LU ; Jóhannesson, Vilberg LU ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
and Gunnlaugsson, Adalsteinn
LU
(2024)
In Advances in Radiation Oncology
9(7).
- Contribution to journal › Article
- 2023
-
Mark
MRI-only radiotherapy from an economic perspective : Can new techniques in prostate cancer treatment be cost saving?
Persson, Emilia LU ; Svanberg, Niklas ; Scherman, Jonas ; Jamtheim Gustafsson, Christian LU ; Fridhammar, Adam ; Hjalte, Frida ; Bäck, Sven LU ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
and Olsson, Lars E
LU
(2023)
In Clinical and Translational Radiation Oncology
38.
p.183-187
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
Bonde, Tiago M ; Garmo, Hans ; Stattin, Pär ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Swanberg, Daniela
and Robinson, David
(2023)
In Acta oncologica (Stockholm, Sweden)
62(12).
p.1815-1821
- Contribution to journal › Article
-
Mark
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors
Adrian, Gabriel LU
; Gebre-Medhin, Maria
LU
and Nilsson, Per
LU
(2023)
In Acta oncologica (Stockholm, Sweden)
62(11).
p.1375-1383
- Contribution to journal › Article
- 2022
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
- Contribution to journal › Article
-
Mark
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
Wennerberg, Johan LU
; Gebre-Medhin, Maria
LU
; Nilsson, Per
LU
; Brun, Eva
LU
; Kjellén, Elisabeth
LU
; Carlwig, Kristin
LU
; Reizenstein, Johan
; Kristiansson, Stefan
; Söderkvist, Karin
and Wahlgren, Magnus
, et al.
(2022)
In Radiotherapy and Oncology
166.
p.26-32
- Contribution to journal › Article
-
Mark
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
Adrian, Gabriel LU
; Carlsson, Henrik
LU
; Kjellén, Elisabeth
LU
; Sjövall, Johanna
LU
; Zackrisson, Björn
; Nilsson, Per
LU
and Gebre-Medhin, Maria
LU
(2022)
In Radiation Oncology
17(1).
- Contribution to journal › Article
- 2021
-
Mark
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
Rasmusson, Elisabeth LU ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
and Gunnlaugsson, Adalsteinn
LU
(2021)
In Advances in Radiation Oncology
6(1).
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
- Contribution to journal › Article